NM_005249.5:c.376G>A
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BS1BP5_StrongBS2
This summary comes from the ClinGen Evidence Repository: The highest population minor allele frequency of the p.Gly126Ser variant in FOXG1 in gnomAD v4.1 is 0.0001782 in European (non-Finnish) population, which is higher than the ClinGen Rett and Angelman-like Disorders VCEP threshold (≥0.00008) for BS1, and therefore meets this criterion (BS1). The p.Gly126Ser variant is observed in at least 2 unaffected individuals (internal database - GeneDx) (BS2). The p.Gly126Ser variant is found in at least 3 patients with an alternate molecular basis of disease (internal database - GeneDx) (BP5_Strong). In summary, the p.Gly126Ser variant in FOXG1 is classified as benign based on the ACMG/AMP criteria (BS1, BS2, BP5_Strong). LINK:https://erepo.genome.network/evrepo/ui/classification/CA314582/MONDO:0100040/035
Frequency
Consequence
NM_005249.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| FOXG1 | ENST00000313071.7 | c.376G>A | p.Gly126Ser | missense_variant | Exon 1 of 1 | 6 | NM_005249.5 | ENSP00000339004.3 | ||
| FOXG1 | ENST00000706482.1 | c.376G>A | p.Gly126Ser | missense_variant | Exon 2 of 2 | ENSP00000516406.1 | ||||
| LINC01551 | ENST00000675861.1 | n.374+1642G>A | intron_variant | Intron 1 of 3 | 
Frequencies
GnomAD3 genomes  0.0000726  AC: 11AN: 151430Hom.:  0  Cov.: 31 show subpopulations 
GnomAD2 exomes  AF:  0.0000525  AC: 4AN: 76180 AF XY:  0.0000760   show subpopulations 
GnomAD4 exome  AF:  0.000152  AC: 200AN: 1318346Hom.:  0  Cov.: 33 AF XY:  0.000138  AC XY: 89AN XY: 644244 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000660  AC: 10AN: 151524Hom.:  0  Cov.: 31 AF XY:  0.0000405  AC XY: 3AN XY: 74044 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Uncertain:1Benign:1 
FOXG1: PP2 -
- -
not specified    Benign:1 
- -
Inborn genetic diseases    Benign:1 
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
FOXG1 disorder    Benign:1 
The highest population minor allele frequency of the p.Gly126Ser variant in FOXG1 in gnomAD v4.1 is 0.0001782 in European (non-Finnish) population, which is higher than the ClinGen Rett and Angelman-like Disorders VCEP threshold (≥0.00008) for BS1, and therefore meets this criterion (BS1). The p.Gly126Ser variant is observed in at least 2 unaffected individuals (internal database - GeneDx) (BS2). The p.Gly126Ser variant is found in at least 3 patients with an alternate molecular basis of disease (internal database - GeneDx) (BP5_Strong). In summary, the p.Gly126Ser variant in FOXG1 is classified as benign based on the ACMG/AMP criteria (BS1, BS2, BP5_Strong). -
Rett syndrome, congenital variant    Benign:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at